Biomarkers for immune checkpoint inhibitors: The importance of tumor topography and the challenges to cytopathology

E-ISSN： 1934-6638|126|1|11-19

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.126, Iss.1, 2018-01, pp. : 11-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune checkpoint inhibitors: new strategies to checkmate cancer

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 191, Iss. 2, 2018-02 ,pp. : 133-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immune checkpoint inhibitors in advanced non–small cell lung cancer

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 248-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 10, 2015-10 ,pp. : 963-976

John Wiley & Sons Inc

Access to resources Recommend Favorite

Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature

Current Drug Safety, Vol. 13, Iss. 3, 2018-11 ,pp. : 150-164

Bentham Science Publishers

Access to resources Recommend Favorite

Role of immunotherapy in lung cancer: Preliminary results of new vaccines and immune checkpoint inhibitors

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. S1, 2015-04 ,pp. : 2-8

John Wiley & Sons Inc

Access to resources Recommend Favorite